BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29369502)

  • 21. Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway.
    Zhu LY; Wu XY; Liu XD; Zheng DF; Li HS; Yang B; Zhang J; Chang Q
    J Neuropathol Exp Neurol; 2020 Jul; 79(7):734-745. PubMed ID: 32417918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic Silencing of DKK3 in medulloblastoma.
    Valdora F; Banelli B; Stigliani S; Pfister SM; Moretti S; Kool M; Remke M; Bai AH; Brigati C; Hielscher T; Romani M; Servidei T; Zollo M; Cinalli G; Oberthuer A; Tonini GP; Coco S
    Int J Mol Sci; 2013 Apr; 14(4):7492-505. PubMed ID: 23567267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
    Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.
    Bezerra Salomão K; Cruzeiro GAV; Bonfim-Silva R; Geron L; Ramalho F; Pinto Saggioro F; Serafini LN; Antunes Moreno D; de Paula Queiroz RG; Dos Santos Aguiar S; Cardinalli I; Yunes JA; Brandalise SR; Brassesco MS; Scrideli CA; Gonzaga Tone L
    J Neurooncol; 2018 Aug; 139(1):33-42. PubMed ID: 29582271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
    Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
    Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors.
    Łastowska M; Trubicka J; Karkucińska-Więckowska A; Kaleta M; Tarasińska M; Perek-Polnik M; Sobocińska AA; Dembowska-Bagińska B; Grajkowska W; Matyja E
    Brain Tumor Pathol; 2019 Jan; 36(1):1-6. PubMed ID: 30523493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
    Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
    Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
    Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance.
    Lindsey JC; Kawauchi D; Schwalbe EC; Solecki DJ; Selby MP; McKinnon PJ; Olson JM; Hayden JT; Grundy RG; Ellison DW; Williamson D; Bailey S; Roussel MF; Clifford SC
    Oncogene; 2015 Sep; 34(36):4746-57. PubMed ID: 25531316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch signaling and natural killer cell infiltration in tumor tissues underlie medulloblastoma prognosis.
    Liang KH; Chang CC; Wu KS; Yu AL; Sung SY; Lee YY; Liang ML; Chen HH; Fen JJ; Chao ME; Liao YT; Wong TT
    Sci Rep; 2021 Dec; 11(1):23282. PubMed ID: 34857809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-21 suppression impedes medulloblastoma cell migration.
    Grunder E; D'Ambrosio R; Fiaschetti G; Abela L; Arcaro A; Zuzak T; Ohgaki H; Lv SQ; Shalaby T; Grotzer M
    Eur J Cancer; 2011 Nov; 47(16):2479-90. PubMed ID: 21775132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups.
    Archer TC; Ehrenberger T; Mundt F; Gold MP; Krug K; Mah CK; Mahoney EL; Daniel CJ; LeNail A; Ramamoorthy D; Mertins P; Mani DR; Zhang H; Gillette MA; Clauser K; Noble M; Tang LC; Pierre-François J; Silterra J; Jensen J; Tamayo P; Korshunov A; Pfister SM; Kool M; Northcott PA; Sears RC; Lipton JO; Carr SA; Mesirov JP; Pomeroy SL; Fraenkel E
    Cancer Cell; 2018 Sep; 34(3):396-410.e8. PubMed ID: 30205044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of medulloblastomas with extensive nodularity (MBEN).
    Korshunov A; Sahm F; Stichel D; Schrimpf D; Ryzhova M; Zheludkova O; Golanov A; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
    Acta Neuropathol; 2018 Aug; 136(2):303-313. PubMed ID: 29569031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
    Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
    J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Classification of Medullobastomas by Whole Genome Expression Profiling.
    Nosková H; Adamcová S; Knoflíčková LDR; Pavelka Z; Vejmělková K; Zitterbart K; Slabý O; Štěrba J
    Klin Onkol; 2019; 32(Supplementum1):171-173. PubMed ID: 31064192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
    Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
    J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated computational analyses reveal novel insights into the stromal microenvironment of SHH-subtype medulloblastoma.
    Landry AP; Samuel N; Spears J; Zador Z
    Sci Rep; 2021 Oct; 11(1):20694. PubMed ID: 34667228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Prognostic Methylation-Driven Two-Gene Signature in Medulloblastoma.
    Michaelsen GL; da Silva LDRE; de Lima DS; Jaeger MDC; Brunetto AT; Dalmolin RJS; Sinigaglia M
    J Mol Neurosci; 2024 Apr; 74(2):47. PubMed ID: 38662144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.
    Dasgupta A; Gupta T; Pungavkar S; Shirsat N; Epari S; Chinnaswamy G; Mahajan A; Janu A; Moiyadi A; Kannan S; Krishnatry R; Sastri GJ; Jalali R
    Neuro Oncol; 2019 Jan; 21(1):115-124. PubMed ID: 29846693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.